Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Jui Ho

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Nature|February 21, 2024
Author Correction: Senolytic CAR T cells reverse senescence-associated pathologiesCorina Amor, Judith Feucht, Josef Leibold, et al.
Developmental Cell|March 24, 2026
Disruption of WNT/Notch signaling in pancreatic cancer reveals tumors depend on the intricate equilibrium of malignant cell statesStefan R Torborg, Jung Yun Kim, Anupriya Singhal, et al.
Cancer Discovery|April 29, 2025
A RAS(ON) multi-selective inhibitor combination therapy triggers long-term tumor control through senescence-associated tumor-immune equilibrium in PDACCaroline Broderick, Riccardo Mezzadra, Exequiel M Sisso, et al.
Nature|June 11, 2025
Metabolic adaptations direct cell fate during tissue regenerationAlmudena Chaves-Perez, Scott E Millman, Sudha Janaki-Raman, et al.
Nature|July 2, 2025
Publisher Correction: Metabolic adaptations direct cell fate during tissue regenerationAlmudena Chaves-Perez, Scott E Millman, Sudha Janaki-Raman, et al.
Nature|May 29, 2020
Phase and context shape the function of composite oncogenic mutationsAlexander N Gorelick, Francisco J Sánchez-Rivera, Yanyan Cai, et al.
Elife|June 1, 2023
MLL3 regulates the <i>CDKN2A</i> tumor suppressor locus in liver cancerChangyu Zhu, Yadira M Soto-Feliciano, John P Morris, et al.
Cancer Discovery|October 27, 2022
Senescence Rewires Microenvironment Sensing to Facilitate Antitumor ImmunityHsuan-An Chen, Yu-Jui Ho, Riccardo Mezzadra, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Metastatic site influences driver gene function in pancreatic cancerKaloyan M Tsanov, Francisco M Barriga, Yu-Jui Ho, et al.
Nature Cancer|November 7, 2022
MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasisFrancisco M Barriga, Kaloyan M Tsanov, Yu-Jui Ho, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Nature|February 21, 2024
Author Correction: Senolytic CAR T cells reverse senescence-associated pathologiesCorina Amor, Judith Feucht, Josef Leibold, et al.
Developmental Cell|March 24, 2026
Disruption of WNT/Notch signaling in pancreatic cancer reveals tumors depend on the intricate equilibrium of malignant cell statesStefan R Torborg, Jung Yun Kim, Anupriya Singhal, et al.
Cancer Discovery|April 29, 2025
A RAS(ON) multi-selective inhibitor combination therapy triggers long-term tumor control through senescence-associated tumor-immune equilibrium in PDACCaroline Broderick, Riccardo Mezzadra, Exequiel M Sisso, et al.
Nature|June 11, 2025
Metabolic adaptations direct cell fate during tissue regenerationAlmudena Chaves-Perez, Scott E Millman, Sudha Janaki-Raman, et al.
Nature|July 2, 2025
Publisher Correction: Metabolic adaptations direct cell fate during tissue regenerationAlmudena Chaves-Perez, Scott E Millman, Sudha Janaki-Raman, et al.
Nature|May 29, 2020
Phase and context shape the function of composite oncogenic mutationsAlexander N Gorelick, Francisco J Sánchez-Rivera, Yanyan Cai, et al.
Elife|June 1, 2023
MLL3 regulates the <i>CDKN2A</i> tumor suppressor locus in liver cancerChangyu Zhu, Yadira M Soto-Feliciano, John P Morris, et al.
Cancer Discovery|October 27, 2022
Senescence Rewires Microenvironment Sensing to Facilitate Antitumor ImmunityHsuan-An Chen, Yu-Jui Ho, Riccardo Mezzadra, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Metastatic site influences driver gene function in pancreatic cancerKaloyan M Tsanov, Francisco M Barriga, Yu-Jui Ho, et al.
Nature Cancer|November 7, 2022
MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasisFrancisco M Barriga, Kaloyan M Tsanov, Yu-Jui Ho, et al.
Pageof 7